Cargando…
Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study
INTRODUCTION: To establish pregnancy, the maternal immune system must adapt to tolerate the semiallogenic fetus. Less than optimal adaptation of the maternal immune system during (early) pregnancy is implicated in several complications of pregnancy. The development of effective immune modulation int...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078247/ https://www.ncbi.nlm.nih.gov/pubmed/30082354 http://dx.doi.org/10.1136/bmjopen-2018-021619 |
_version_ | 1783345058474360832 |
---|---|
author | Prins, Jelmer R Holvast, Floor van ’t Hooft, Janneke Bos, Arend F Ganzevoort, Jan Willem Scherjon, Sicco A Robertson, Sarah A Gordijn, Sanne J |
author_facet | Prins, Jelmer R Holvast, Floor van ’t Hooft, Janneke Bos, Arend F Ganzevoort, Jan Willem Scherjon, Sicco A Robertson, Sarah A Gordijn, Sanne J |
author_sort | Prins, Jelmer R |
collection | PubMed |
description | INTRODUCTION: To establish pregnancy, the maternal immune system must adapt to tolerate the semiallogenic fetus. Less than optimal adaptation of the maternal immune system during (early) pregnancy is implicated in several complications of pregnancy. The development of effective immune modulation interventions as preventive or therapeutic strategies for pregnancy complications holds promise. Several studies sought to evaluate the safety and effectiveness of various approaches. However, a limitation is the high variability in clinical and immune outcomes that are reported. We, therefore, aim to develop a core outcome set for application to studies of immune modulation in pregnancy (COSIMPREG). METHODS AND ANALYSIS: We will use a stepwise approach to develop a COSIMPREG. First, we will perform a systematic review to identify reported outcomes. For this review, Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines will be followed. Second, we will use the Delphi method to develop a preliminary COSIMPREG. In three rounds, the outcomes of the systematic review will be scored. A panel comprising experts from relevant disciplines and diverse geographical locations will be assembled until a sufficient quality of the panel is reached. We will use predefined decision rules for outcomes. After each round outcomes, including scores, will be returned to the panel for further refinement. The outcomes not excluded after the third round will be taken to a consensus meeting. In this meeting, experts from all relevant disciplines will discuss and finalise the COSIMPREG. ETHICS AND DISSEMINATION: For this study ethical approval is not required. The systematic review will be published in an appropriate open access reproductive immunology journal. Once the COSIMPREG is finalised, it will be published in an open access reproductive immunology journal, and disseminated at appropriate international meetings, as well as through relevant research and scientific societies. Experts involved in the Delphi study will be asked to give informed consent. |
format | Online Article Text |
id | pubmed-6078247 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-60782472018-08-09 Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study Prins, Jelmer R Holvast, Floor van ’t Hooft, Janneke Bos, Arend F Ganzevoort, Jan Willem Scherjon, Sicco A Robertson, Sarah A Gordijn, Sanne J BMJ Open Obstetrics and Gynaecology INTRODUCTION: To establish pregnancy, the maternal immune system must adapt to tolerate the semiallogenic fetus. Less than optimal adaptation of the maternal immune system during (early) pregnancy is implicated in several complications of pregnancy. The development of effective immune modulation interventions as preventive or therapeutic strategies for pregnancy complications holds promise. Several studies sought to evaluate the safety and effectiveness of various approaches. However, a limitation is the high variability in clinical and immune outcomes that are reported. We, therefore, aim to develop a core outcome set for application to studies of immune modulation in pregnancy (COSIMPREG). METHODS AND ANALYSIS: We will use a stepwise approach to develop a COSIMPREG. First, we will perform a systematic review to identify reported outcomes. For this review, Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines will be followed. Second, we will use the Delphi method to develop a preliminary COSIMPREG. In three rounds, the outcomes of the systematic review will be scored. A panel comprising experts from relevant disciplines and diverse geographical locations will be assembled until a sufficient quality of the panel is reached. We will use predefined decision rules for outcomes. After each round outcomes, including scores, will be returned to the panel for further refinement. The outcomes not excluded after the third round will be taken to a consensus meeting. In this meeting, experts from all relevant disciplines will discuss and finalise the COSIMPREG. ETHICS AND DISSEMINATION: For this study ethical approval is not required. The systematic review will be published in an appropriate open access reproductive immunology journal. Once the COSIMPREG is finalised, it will be published in an open access reproductive immunology journal, and disseminated at appropriate international meetings, as well as through relevant research and scientific societies. Experts involved in the Delphi study will be asked to give informed consent. BMJ Publishing Group 2018-08-05 /pmc/articles/PMC6078247/ /pubmed/30082354 http://dx.doi.org/10.1136/bmjopen-2018-021619 Text en © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Obstetrics and Gynaecology Prins, Jelmer R Holvast, Floor van ’t Hooft, Janneke Bos, Arend F Ganzevoort, Jan Willem Scherjon, Sicco A Robertson, Sarah A Gordijn, Sanne J Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study |
title | Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study |
title_full | Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study |
title_fullStr | Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study |
title_full_unstemmed | Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study |
title_short | Development of a core outcome set for immunomodulation in pregnancy (COSIMPREG): a protocol for a systematic review and Delphi study |
title_sort | development of a core outcome set for immunomodulation in pregnancy (cosimpreg): a protocol for a systematic review and delphi study |
topic | Obstetrics and Gynaecology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078247/ https://www.ncbi.nlm.nih.gov/pubmed/30082354 http://dx.doi.org/10.1136/bmjopen-2018-021619 |
work_keys_str_mv | AT prinsjelmerr developmentofacoreoutcomesetforimmunomodulationinpregnancycosimpregaprotocolforasystematicreviewanddelphistudy AT holvastfloor developmentofacoreoutcomesetforimmunomodulationinpregnancycosimpregaprotocolforasystematicreviewanddelphistudy AT vanthooftjanneke developmentofacoreoutcomesetforimmunomodulationinpregnancycosimpregaprotocolforasystematicreviewanddelphistudy AT bosarendf developmentofacoreoutcomesetforimmunomodulationinpregnancycosimpregaprotocolforasystematicreviewanddelphistudy AT ganzevoortjanwillem developmentofacoreoutcomesetforimmunomodulationinpregnancycosimpregaprotocolforasystematicreviewanddelphistudy AT scherjonsiccoa developmentofacoreoutcomesetforimmunomodulationinpregnancycosimpregaprotocolforasystematicreviewanddelphistudy AT robertsonsaraha developmentofacoreoutcomesetforimmunomodulationinpregnancycosimpregaprotocolforasystematicreviewanddelphistudy AT gordijnsannej developmentofacoreoutcomesetforimmunomodulationinpregnancycosimpregaprotocolforasystematicreviewanddelphistudy |